对乙酰氨基酚术后静脉镇痛的最佳时机。

Q3 Medicine
Maho Shinoda, Akiko Nishimura, Erika Sugiyama, Hitoshi Sato, Takehiko Iijima
{"title":"对乙酰氨基酚术后静脉镇痛的最佳时机。","authors":"Maho Shinoda,&nbsp;Akiko Nishimura,&nbsp;Erika Sugiyama,&nbsp;Hitoshi Sato,&nbsp;Takehiko Iijima","doi":"10.2344/anpr-69-02-05","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Acetaminophen (APAP) is widely used as an analgesic for postoperative pain relief. However, the pharmacokinetic-pharmacodynamic (PK-PD) properties of intravenous APAP administration remain unclear. We developed a PK-PD model in adult volunteers.</p><p><strong>Methods: </strong>APAP (1 g) was intravenously administered to 15 healthy volunteers. The pain equivalent current (PEC) was then measured using the pulse current, corresponding to the quantitative value of pain perception. The PK model was developed using a 2-compartment model, and the PD model was developed using a linear model and an effect compartment model.</p><p><strong>Results: </strong>APAP plasma concentration peaked just administration, whereas PEC significantly increased at 90 minutes and lasted through the experimental period (300 minutes). APAP plasma concentrations and PEC were processed for use in the PK-PD model. The developed PK-PD model delineates the analgesic effect profile, which peaked at 188 minutes and lasted until 327 minutes.</p><p><strong>Conclusion: </strong>We developed the PK/PD model for APAP administered intravenously. The analgesic effect can be expected ∼90 minutes after administration and to last >5 hours. It is suggested that APAP be administered ∼90 minutes prior to the onset of anticipated postoperative pain.</p>","PeriodicalId":7818,"journal":{"name":"Anesthesia progress","volume":" ","pages":"3-10"},"PeriodicalIF":0.0000,"publicationDate":"2022-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9301534/pdf/i1878-7177-69-2-3.pdf","citationCount":"0","resultStr":"{\"title\":\"Optimal Timing of Intravenous Acetaminophen Administration for Postoperative Analgesia.\",\"authors\":\"Maho Shinoda,&nbsp;Akiko Nishimura,&nbsp;Erika Sugiyama,&nbsp;Hitoshi Sato,&nbsp;Takehiko Iijima\",\"doi\":\"10.2344/anpr-69-02-05\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>Acetaminophen (APAP) is widely used as an analgesic for postoperative pain relief. However, the pharmacokinetic-pharmacodynamic (PK-PD) properties of intravenous APAP administration remain unclear. We developed a PK-PD model in adult volunteers.</p><p><strong>Methods: </strong>APAP (1 g) was intravenously administered to 15 healthy volunteers. The pain equivalent current (PEC) was then measured using the pulse current, corresponding to the quantitative value of pain perception. The PK model was developed using a 2-compartment model, and the PD model was developed using a linear model and an effect compartment model.</p><p><strong>Results: </strong>APAP plasma concentration peaked just administration, whereas PEC significantly increased at 90 minutes and lasted through the experimental period (300 minutes). APAP plasma concentrations and PEC were processed for use in the PK-PD model. The developed PK-PD model delineates the analgesic effect profile, which peaked at 188 minutes and lasted until 327 minutes.</p><p><strong>Conclusion: </strong>We developed the PK/PD model for APAP administered intravenously. The analgesic effect can be expected ∼90 minutes after administration and to last >5 hours. It is suggested that APAP be administered ∼90 minutes prior to the onset of anticipated postoperative pain.</p>\",\"PeriodicalId\":7818,\"journal\":{\"name\":\"Anesthesia progress\",\"volume\":\" \",\"pages\":\"3-10\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9301534/pdf/i1878-7177-69-2-3.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Anesthesia progress\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2344/anpr-69-02-05\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Anesthesia progress","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2344/anpr-69-02-05","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

摘要

目的:对乙酰氨基酚(APAP)是一种广泛应用于术后镇痛的药物。然而,静脉给药APAP的药代动力学-药效学(PK-PD)特性尚不清楚。我们建立了成人志愿者的PK-PD模型。方法:15名健康志愿者静脉注射APAP (1 g)。然后使用脉冲电流测量疼痛等效电流(PEC),与疼痛感知的定量值相对应。采用2室模型建立PK模型,采用线性模型和效应室模型建立PD模型。结果:APAP血浆浓度在给药时达到峰值,而PEC在给药90分钟时显著升高,并持续到实验期间(300分钟)。APAP血浆浓度和PEC处理用于PK-PD模型。建立的PK-PD模型描绘了镇痛效果的概况,镇痛效果在188分钟达到顶峰,持续到327分钟。结论:建立静脉给药APAP的PK/PD模型。镇痛作用可在给药后约90分钟,并持续>5小时。建议在预期的术后疼痛开始前90分钟施用APAP。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Optimal Timing of Intravenous Acetaminophen Administration for Postoperative Analgesia.

Optimal Timing of Intravenous Acetaminophen Administration for Postoperative Analgesia.

Optimal Timing of Intravenous Acetaminophen Administration for Postoperative Analgesia.

Objective: Acetaminophen (APAP) is widely used as an analgesic for postoperative pain relief. However, the pharmacokinetic-pharmacodynamic (PK-PD) properties of intravenous APAP administration remain unclear. We developed a PK-PD model in adult volunteers.

Methods: APAP (1 g) was intravenously administered to 15 healthy volunteers. The pain equivalent current (PEC) was then measured using the pulse current, corresponding to the quantitative value of pain perception. The PK model was developed using a 2-compartment model, and the PD model was developed using a linear model and an effect compartment model.

Results: APAP plasma concentration peaked just administration, whereas PEC significantly increased at 90 minutes and lasted through the experimental period (300 minutes). APAP plasma concentrations and PEC were processed for use in the PK-PD model. The developed PK-PD model delineates the analgesic effect profile, which peaked at 188 minutes and lasted until 327 minutes.

Conclusion: We developed the PK/PD model for APAP administered intravenously. The analgesic effect can be expected ∼90 minutes after administration and to last >5 hours. It is suggested that APAP be administered ∼90 minutes prior to the onset of anticipated postoperative pain.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Anesthesia progress
Anesthesia progress Medicine-Medicine (all)
CiteScore
0.90
自引率
0.00%
发文量
32
期刊介绍: Anesthesia Progress is a peer-reviewed journal and the official publication of the American Dental Society of Anesthesiology. The journal is dedicated to providing a better understanding of the advances being made in the art and science of pain and anxiety control in dentistry.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信